Back to top

Study of the cellular and molecular pharmacology of the urotensinergic system

  • Doctorate
  • Fall
  • With scholarship

Project Description

The urotensinergic system, composed of a G protein-coupled receptor (UT) and two endogenous ligands, has garnered significant attention due to its involvement in the initiation and/or the evolution of various cardiovascular diseases. Unfortunately, despite a proven efficacy in various animal models, initial clinical investigation of candidate UT antagonists showed limited efficacy in humans. Failure to appreciate 1) the impact of interspecies variability, 2) to consider potential biased agonism and possible probe-dependent action of UT antagonists at the preclinical stage probably contributed to these translational failures. This system remains to be exploited therapeutically. However, the development of effective ligands remains complicated due to our limited understanding of downstream ligand-receptor-effector interactions and the impact of interspecies variability. The objectives of this doctoral project are therefore to:

  • Develop new peptidic ligands/biased agonists/allosteric modulators targeting UT.
  • Identify the structural and physico-chemical determinants responsible for their biological activities (probe-dependent effect, biased agonism, etc.).
  • Study the phenotypic responses of the latter in a model of human cells (cardiomyocytes derived from induced pluripotent cells (iPSCs-CMs) – collaboration with Pr. Hébert, McGill University).

Research Areas

  • Medicinal Chemistry
  • Pharmacology
  • Cellular and Molecular Biology

Research Supervisor

  • David Chatenet, Professor
  • Terence E. Hébert, Professor (McGill university)
  • Juliana Dallagnol, Research Associate

Study Programs

This study project will be carried out under the following program: Ph.D. in Biology (French description)

Desired Profile

  • Hold a master’s degree in biology, biochemistry, pharmacology, chemistry, or a related research field;
  • Be open to collaborating with an interdisciplinary team working in different research areas;
  • Have a curious, resourceful, and autonomous mindset;
  • Have a good fluency on both French and English.

Applicants with knowledge or experience in some or all of the following areas are encouraged to apply:

  • GPCR pharmacology
  • Organic/peptidic synthesis
  • Compounds purification using various chromatographic methods
  • Cell biology

Financial Support

INRS offers many scholarship programs (in french). Every student will benefit from a scholarship during their higher education studies.

Location

Centre Armand-Frappier Santé Biotechnologie
531, boulevard des Prairies
Laval (Québec) H7V 1B7

How to apply

Interested persons can submit their application in a single PDF file by using the online form.

The application must include:

  • Motivation letter describing their research interests
  • Complete CV
  • a statement of all your academic transcripts
  • The name of three contact information for further reference.

We encourage women, visible minorities, ethnic minorities, aboriginals and people with disabilities to apply.

David Chatenet - Study of the cellular and molecular pharmacology of the urotensinergic system

Project title : Study of the cellular and molecular pharmacology of the urotensinergic system

Curriculum vitæ (CV) *

Maximum file size: 5MB

Academic transcript *

Maximum file size: 8MB

Letter of interests *

Maximum file size: 5MB

Three (3) references *

Maximum file size: 5MB

How did you hear about this study project?